Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Cyclin A activity predicts clinical outcome in oral precancer and cancer.

Thomson PJ, Goodson ML, Booth C, Cragg N, Hamadah O.

Int J Oral Maxillofac Surg. 2006 Nov;35(11):1041-6. Epub 2006 Sep 7.

PMID:
16962288
2.

Predicting recurrence after oral precancer treatment: use of cell cycle analysis.

Thomson PJ, Hamadah O, Goodson ML, Cragg N, Booth C.

Br J Oral Maxillofac Surg. 2008 Jul;46(5):370-5. doi: 10.1016/j.bjoms.2008.01.003. Epub 2008 Feb 20.

PMID:
18282643
3.

Epithelial cell proliferative activity and oral cancer progression.

Thomson PJ, Soames JV, Booth C, O'Shea JA.

Cell Prolif. 2002 Aug;35 Suppl 1:110-20.

PMID:
12139714
4.

Immunohistochemical study of p53 and angiogenesis in benign and preneoplastic oral lesions and oral squamous cell carcinoma.

Abbas NF, Labib El-Sharkawy S, Abbas EA, Abdel Monem El-Shaer M.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 Mar;103(3):385-90. Epub 2006 Jun 30.

PMID:
17321451
5.

Interventional laser surgery: an effective surgical and diagnostic tool in oral precancer management.

Thomson PJ, Wylie J.

Int J Oral Maxillofac Surg. 2002 Apr;31(2):145-53.

PMID:
12102411
6.

Clinicopathological behaviour of multiple oral dysplastic lesions compared with that of single lesions.

Hamadah O, Goodson ML, Thomson PJ.

Br J Oral Maxillofac Surg. 2010 Oct;48(7):503-6. doi: 10.1016/j.bjoms.2009.08.027. Epub 2009 Oct 2.

PMID:
19800717
7.

Factors affecting carbon dioxide laser treatment for oral precancer: a patient cohort study.

Hamadah O, Thomson PJ.

Lasers Surg Med. 2009 Jan;41(1):17-25. doi: 10.1002/lsm.20733.

PMID:
19143013
8.

Expression of Ki-67 and p53 in cutaneous free flaps used to reconstruct soft tissue defects following resection of oral squamous cell carcinoma.

Max Robinson C, Prime SS, Paterson IC, Guest PG, Eveson JW.

Oral Oncol. 2007 Mar;43(3):263-71. Epub 2006 Aug 22.

PMID:
16920383
9.

Comparison of BrdU and cyclin A as markers of the S-phase in oral precancerous lesions.

Oliver RJ, MacDonald DG.

J Oral Pathol Med. 2000 Oct;29(9):426-31.

PMID:
11016684
10.

CD44v6 in developing, dysplastic and malignant oral epithelia.

Rautava J, Soukka T, Inki P, Leimola-Virtanen R, Saloniemi I, Happonen RP, Heikinheimo K.

Oral Oncol. 2003 Jun;39(4):373-9.

PMID:
12676257
11.

Immunohistochemical markers of proliferation and vascularisation in preneoplastic bronchial lesions and invasive non-small cell lung cancer.

Cavarga I, Kocan P, Boor A, Belak J, Zak V, Kluchova Z, Slavik L, Tkacova R.

Neoplasma. 2009;56(5):414-21.

PMID:
19580343
12.

Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.

Khalifeh IM, Albarracin C, Diaz LK, Symmans FW, Edgerton ME, Hwang RF, Sneige N.

Am J Surg Pathol. 2008 Apr;32(4):544-52. doi: 10.1097/PAS.0b013e31815a87e2.

PMID:
18300793
13.

MGMT expression in oral precancerous and cancerous lesions: correlation with progression, nodal metastasis and poor prognosis.

Sawhney M, Rohatgi N, Kaur J, Gupta SD, Deo SV, Shukla NK, Ralhan R.

Oral Oncol. 2007 May;43(5):515-22. Epub 2006 Sep 25.

PMID:
16996781
14.

Diagnostic and prognostic significance of cyclin A expression in low-grade astrocytomas: comparison with astrogliosis and high-grade tumours.

Hara A, Saegusa M, Ichinoe M, Okayasu I.

J Clin Pathol. 2008 Mar;61(3):287-92. Epub 2007 Dec 21.

PMID:
18156430
15.

Skp2 is an independent prognosticator of gallbladder carcinoma among p27(Kip1)-interacting cell cycle regulators: an immunohistochemical study of 62 cases by tissue microarray.

Li SH, Li CF, Sung MT, Eng HL, Hsiung CY, Huang WW, Lin CN, Yu SC, Huang HY.

Mod Pathol. 2007 Apr;20(4):497-507. Epub 2007 Mar 2.

16.

Cell cycle dysregulation influences survival in high risk breast cancer patients.

Königsberg R, Rögelsperger O, Jäger W, Thalhammer T, Klimpfinger M, De Santis M, Hudec M, Dittrich C.

Cancer Invest. 2008 Aug;26(7):734-40. doi: 10.1080/07357900801944864.

PMID:
18665474
17.

Expression of p16, p53 and Ki-67 proteins in the progression of epithelial dysplasia of the oral cavity.

Angiero F, Berenzi A, Benetti A, Rossi E, Del Sordo R, Sidoni A, Stefani M, Dessy E.

Anticancer Res. 2008 Sep-Oct;28(5A):2535-9.

18.

Vascular endothelial growth factor a and proliferation marker in prediction of lymph node metastasis in oral and pharyngeal squamous cell carcinoma.

Boonkitticharoen V, Kulapaditharom B, Leopairut J, Kraiphibul P, Larbcharoensub N, Cheewaruangroj W, Chintrakarn C, Pochanukul L.

Arch Otolaryngol Head Neck Surg. 2008 Dec;134(12):1305-11. doi: 10.1001/archotol.134.12.1305.

PMID:
19075127
19.

Characterization of epithelial cell activity in patients with oral cancer.

Thomson PJ, Potten CS, Appleton DR.

Br J Oral Maxillofac Surg. 1999 Oct;37(5):384-90.

PMID:
10577753
20.

Quantification of telomerase activity of regions unstained with iodine solution that surround oral squamous cell carcinoma.

Yajima Y, Noma H, Furuya Y, Nomura T, Yamauchi T, Kasahara K, Hatada K, Takano M.

Oral Oncol. 2004 Mar;40(3):314-20.

PMID:
14747063
Items per page

Supplemental Content

Write to the Help Desk